Efficacy of Hibiscus sabdariffa L. extract on metabolic parameters in participants with abdominal obesity and mild metabolic syndrome in Bangkok, Thailand: A double-blind, randomized, placebo-controlled trial
Complementary Therapies in Medicine · 2025-08 · 91 · 103185
DOI: 10.1016/j.ctim.2025.103185 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Complementary Therapies in Medicine, 2025-08. Verfasst von Kanchaporn Chaisungnern und 9 weiteren Autor:innen. Beteiligte Einrichtung: Health Research and Management Program, Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailan…. Hauptthemen laut MEDLINE: Hibiscus, Metabolic Syndrome, Obesity, Abdominal, Plant Extracts. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chulalongkorn University, Chulalongkorn University Faculty of Medicine, Ministry of Public Health.
Abstract (Originalsprache)
BACKGROUND: Hibiscus sabdariffa L. (HS) has been investigated as an alternative treatment for metabolic syndrome (MetS), as it affects all MetS components with low side effects simultaneously; however, clinical evidence regarding its efficacy compared with placebo is inconsistent. This study assessed how the aqueous calyx extract of HS influences insulin resistance and MetS parameters and examined the safety effects on liver, kidney, and hematological indexes in participants with abdominal obesity and mild MetS symptoms. METHODS: In this double-blind, randomized, placebo-controlled trial, 108 participants with MetS were randomly assigned to take 1000-mg HS (45.04 mg/day in total polyphenols) or placebo daily for 12 weeks. Insulin resistance (HOMA-IR), glycemic markers, body mass index (BMI), waist circumference (WC), lipid profiles, and blood pressure were assessed at baseline, 6 weeks, and 12 weeks. Additionally, liver and kidney function indicators along with hematological parameters were evaluated. RESULTS: Compared with placebo, HS did not significantly affect HOMA-IR, glycemic markers, BMI, WC, lipid profile, or blood pressure. Although HS did not significantly alter the lipid profile overall, serum low-density lipoprotein (LDL) levels decreased significantly at 12 weeks compared with baseline (- 7.98 mg/dL, [95 % CI, - 14.80, - 1.15]). Additionally, HS did not cause significant liver or kidney function or hematological changes compared with placebo. CONCLUSION: Taking 1000-mg HS daily for 12 weeks seems to be safe. Placebo and HS groups showed good clinical results, and the extract was not associated with improved metabolic parameters in individuals with abdominal obesity and mild MetS symptoms, with the exception of lower serum LDL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health Research and Management Program, Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Electronic address: kanchapcn@gmail.com.
- Health Research and Management Program, Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. Electronic address: athanapoom@gmail.com.
- Institute of Thai Traditional Medicine, Department of Thai Traditional and Alternative Medicine, Ministry of Public Health, Thailand. Electronic address: rossukon.klin@gmail.com.
- Institute of Thai Traditional Medicine, Department of Thai Traditional and Alternative Medicine, Ministry of Public Health, Thailand. Electronic address: srisuphak2004@gmail.com.
- Institute of Thai Traditional Medicine, Department of Thai Traditional and Alternative Medicine, Ministry of Public Health, Thailand. Electronic address: kamonaor369@gmail.com.
- Center of Excellence in Applied Thai Traditional Medicine Research, Thammasat University, Thailand. Electronic address: iarunporn@yahoo.com.
Förderung
- Chulalongkorn University
- Chulalongkorn University Faculty of Medicine
- Ministry of Public Health
- Chulalongkorn University Graduate School
Zitieren
APA
Chaisungnern, K., Rattananupong, T., Klinhom, R., Nanta, S., Banchuen, K., Itharat, A., Kuropakornpong, P., Supasiri, T., Nootim, P., & Jiamjarasrangsi, W. (2025). Efficacy of Hibiscus sabdariffa L. extract on metabolic parameters in participants with abdominal obesity and mild metabolic syndrome in Bangkok, Thailand: A double-blind, randomized, placebo-controlled trial. Complementary Therapies in Medicine, 91, 103185. https://doi.org/10.1016/j.ctim.2025.103185
Vancouver
Chaisungnern K, Rattananupong T, Klinhom R, Nanta S, Banchuen K, Itharat A, et al. Efficacy of Hibiscus sabdariffa L. extract on metabolic parameters in participants with abdominal obesity and mild metabolic syndrome in Bangkok, Thailand: A double-blind, randomized, placebo-controlled trial. Complementary Therapies in Medicine. 2025;91:103185. doi:10.1016/j.ctim.2025.103185
BibTeX
@article{Chaisungnern2025,
author = {Chaisungnern, Kanchaporn and Rattananupong, Thanapoom and Klinhom, Rossukon and Nanta, Srisuphak and Banchuen, Kamonwan and Itharat, Arunporn and Kuropakornpong, Pranporn and Supasiri, Thanan and Nootim, Preecha and Jiamjarasrangsi, Wiroj},
title = {Efficacy of Hibiscus sabdariffa L. extract on metabolic parameters in participants with abdominal obesity and mild metabolic syndrome in Bangkok, Thailand: A double-blind, randomized, placebo-controlled trial},
journal = {Complementary Therapies in Medicine},
year = {2025},
volume = {91},
pages = {103185},
doi = {10.1016/j.ctim.2025.103185}
}
EUVIMED